REYON Pharmaceutical Co., Ltd. (KRX:102460)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,960.00
-80.00 (-0.80%)
Apr 2, 2026, 3:30 PM KST
Market Cap182.68B -17.5%
Revenue (ttm)149.34B -0.3%
Net Income-14.25B
EPS-773.90
Shares Out18.34M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume41,273
Average Volume34,112
Open10,150.00
Previous Close10,040.00
Day's Range9,800.00 - 10,150.00
52-Week Range9,580.00 - 14,430.00
Beta0.54
RSI34.58
Earnings DateMar 20, 2026

About REYON Pharmaceutical

REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; ... [Read more]

Sector Healthcare
Founded 1955
Employees 448
Stock Exchange Korea Stock Exchange
Ticker Symbol 102460
Full Company Profile

Financial Performance

In 2024, REYON Pharmaceutical's revenue was 148.30 billion, a decrease of -1.83% compared to the previous year's 151.07 billion. Earnings were 4.15 billion, an increase of 15.85%.

Financial Statements